Increased CXCL10 expression in nasal fibroblasts from patients with refractory chronic rhinosinusitis and asthma

Allergology International

Volumn 62, Issue 4, 2013, Pages 495-502

  Yoshikawa, Mamoru ^a   Wada, Kota ^b   Yoshimura, Tsuyoshi ^b   Asaka, Daiya ^b   Okada, Naoko ^c   Matsumoto, Kenji ^c   Moriyama, Hiroshi ^b  

^a TOHO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Asthma; CXCL10 chemokine; Fibroblast; Nasal polyps; Rhinosinusitis

Indexed keywords

ACETYLSALICYLIC ACID; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CELL ISOLATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NASAL BIOPSY; NASAL FIBROBLAST; NOSE MUCOSA; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; ASTHMA; ASTHMA, ASPIRIN-INDUCED; CELLS, CULTURED; CHEMOKINE CXCL10; CHRONIC DISEASE; DRUG RESISTANCE; FEMALE; FIBROBLASTS; GATA3 TRANSCRIPTION FACTOR; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PARANASAL SINUSES; POLY I-C; RHINITIS; SINUSITIS; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84890069733     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.13-OA-0572     Document Type: Article

References (45)

1. Kalish LH, Arendts G, Sacks R, Craig JC. Topical steroids in chronic rhinosinusitis without polyps: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2009; 141:674-83.
2. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007;45:259-67.
3. Moriyama H, Yanagi K, Ohtori N, Fukami M. Evaluation of endoscopic sinus surgery for chronic sinusitis: postoperative erythromycin therapy. Rhinology 1995;33:166-70.
4. Drake-Lee AB. Medical treatment of nasal polyps. Rhinology 1994;32:1-4.
5. Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 1999;54(Suppl 53):7-11.
6. Ediger D, Sin BA, Heper A, Anadolu Y, Misirligil Z. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy 2005;35: 319-26.
7. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2004; 12:237-42.
8. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000;27:247-52.
9. Terada N, Hamano N, Nomura T et al. Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 2000;30:348-55.
10. Winther B, Gwaltney JM Jr, Mygind N, Hendley JO. Viralinduced rhinitis. Am J Rhinol 1998;12:17-20.
11. Yoneyama M, Kikuchi M, Natsukawa T et al. The RNA helicase RIG-I has an essential function in doublestranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-7.
12. Chen Y, Nickola TJ, DiFronzo NL, Colberg-Poley AM, Rose MC. Dexamethasone-mediated repression of MUC5 AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2006;34:338-47.
13. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005;289:L85-95.
14. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997;52:380-9.
15. Bardin PG, Johnston SL, Sanderson G et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol 1994; 10:207-13.
16. Ghildyal R, Dagher H, Donninger H et al. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol 2005;75:608-15.
17. Matsumoto M, Funami K, Oshiumi H, Seya T. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 2004;48:147-54.
18. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
19. Liu MT, Chen BP, Oertel P et al. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000; 165:2327-30.
20. Watarai Y, Koga S, Paolone DR et al. Intraallograft chemokine RNA and protein during rejection of MHCmatched _multiple minor histocompatibility-disparate skin grafts. J Immunol 2000;164:6027-33.
21. Narumi S, Kaburaki T, Yoneyama H, Iwamura H, Kobayashi Y, Matsushima K. Neutralization of IFN-inducible protein 10_CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2002;32:1784-91.
22. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001;22:199-204.
23. Platt MP, Soler ZM, Kao S-Y, Metson R, Stankovic KM. Topographic gene expression in the sinonasal cavity of patients with chronic sinusitis with polyps. Otolaryngol Head Neck Surg 2011;145:171-5.
24. Ohmori Y, Hamilton TA. Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma-and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem1993;268:6677-88.
25. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NFkappaB by Toll-like receptor 3. Nature 2001;413:732-8.
26. Fitzgerald KA, Rowe DC, Barnes BJ et al. LPS-TLR4 signaling to IRF-3_7 and NF-kappaB involves the toll adapters TRAM and TRIF. J ExpMed 2003;198:1043-55.
27. Servant MJ, Grandvaux N, tenOever BR, Duguay D, Lin R, Hiscott J. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J Biol Chem2003;278:9441-7.
28. Sharma RP, He Q, Johnson VJ. Deletion of IFN-gamma reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors. J Interferon Cytokine Res 2003;23:13-23.
29. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFNbeta enhancer in vivo. Mol Cell 1998;1:507-18.
30. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP_p300. EMBO J 1998; 17:1087-95.
31. Guo Y, Ge J, LiuHet al. Bifunctional effect of human IFNgamma on cultured human fibroblasts from Tenon's capsule. Yan Ke Xue Bao 2000;16:43-7.
32. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, Smiley JR. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001; 75:750-8.
33. Bedke N, Haitchi HM, Xatzipsalti M, Holgate ST, Davies DE. Contribution of bronchial fibroblasts to the antiviral response in asthma. J Immunol 2009;182:3660-7.
34. Wark PA, Bucchieri F, Johnston SL et al. IFN-gammainduced protein 10 is a novel biomarker of rhinovirusinduced asthma exacerbations. J Allergy Clin Immunol 2007;120:586-93.
35. Matsukura S, Kokubu F, Kurokawa M et al. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and_or IRF-3 in airway epithelial cells. Clin Exp Allergy 2006;36:1049-62.
36. Proost P, Verpoest S, Van de Borne K et al. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 2004;75:777-84.
37. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 1998;54:2152-9.
38. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997;151:317-22.
39. Valera FC, Queiroz R, Scrideli C, Tone LG, Anselmo-Lima WT. Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis. Clin Exp Allergy 2008;38:579-85.
40. Alrashdan YA, Alkhouri H, Chen E et al. Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol 2012;302:L1118-27.
41. Wang Q, Nagarkar DR, Bowman ER et al. Role of doublestranded RNA pattern recognition receptors in rhinovirusinduced airway epithelial cell responses. J Immunol 2009; 183:6989-97.
42. Takaku Y, Nakagome K, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M. IFN-gamma-inducible protein of 10 kDa upregulates the effector functions of eosinophils through beta2 integrin and CXCR3. Respir Res 2011;12: 138.
43. Hoerning A, Koss K, Datta D et al. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol 2011;41:2291-302.
44. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-21. quiz 22.
45. Dhong HJ, Kim HY, Cho DY. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Otolaryngol 2005;125:169-76.